Prodec

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Prodec

Property Description
Active Ingredient Allopurinol
Form Tablet (Oral) and Powder for Solution (Intravenous)
Pharmacological Class Xanthine Oxidase Inhibitor (XOI)
General Purpose To lower the body's uric acid levels
Origin Synthetic Compound, Purine Analogue

What is Prodec? (Active Ingredient, Class, and Purpose)

Prodec is a trade name for the drug whose active ingredient is Allopurinol, a synthetic compound classified pharmacologically as a Xanthine Oxidase Inhibitor (XOI). This medication functions as an antihyperuricemic agent, meaning its core general purpose is centered on controlling and lowering the body’s levels of uric acid. The use of Allopurinol is widely recognized for its role in managing chronic metabolic conditions.

The drug entity Allopurinol is specifically a purine analogue that modifies the natural metabolic pathway, preventing the final formation of the crystalline substance. This compound helps manage elevated levels of serum urate, serving as a standard approach for long-term metabolic stabilization.

Pharmaceutical Presentation and High-Level Composition

Allopurinol is primarily presented as an oral tablet for routine management, but it is also prepared as a sterile powder for solution used in specialized intravenous (IV) administration. As a single-ingredient product, the composition consists solely of the active chemical Allopurinol combined with standard pharmaceutical excipients for the oral form, or a sterile solvent for the injectable preparation.

The specialized formulation of Allopurinol for intravenous administration ensures its utility beyond standard oral care, making it a critical compound for managing acute metabolic imbalances. This versatility differentiates it from medications available solely in the oral tablet form.

The General Action: Targeting Uric Acid Production

The principal function of Allopurinol is to reduce the concentration of serum urate by blocking the production of uric acid, the end-product of purine metabolism. The drug, along with its active metabolite oxipurinol, achieves this by selectively inhibiting the enzyme xanthine oxidase. This action ensures that the total amount of serum urate circulating in the blood and urine is diminished.

What side effects are possible with Prodec?

Possible Side Effects and Safety Information

The safety profile of Prodec (Allopurinol) is characterized by adverse reactions formally classified by regulatory authorities based on their frequency and the body system affected. These classifications structure the official risk landscape by identifying common events and isolating rare, high-severity concerns.


Frequency-Classified Adverse Reactions

Adverse effects are categorized by their expected frequency:

  • Common Reactions (may affect up to 1 in 10 patients) often include simple skin rash, gastrointestinal disturbances (such as nausea and vomiting), and asymptomatic elevations in liver enzyme levels. An increase in acute gout attacks may also occur early in treatment.
  • Uncommon to Rare Reactions encompass more serious effects, including various forms of hepatitis (liver injury), renal failure, and disorders of the blood and lymphatic system (e.g., bone marrow suppression).

Serious Adverse Reactions

The most clinically significant risks explicitly documented in regulatory labels involve Hypersensitivity Reactions (HSR) and Severe Cutaneous Adverse Reactions (SCARs). These include Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), and Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS). These rare events typically require immediate discontinuation of the medication.


Population and Regulatory Safety Notes

Official prescribing information includes specific safety considerations for certain populations. Patients with impaired renal function are at a heightened risk of hypersensitivity and require careful monitoring. Furthermore, official documents note a genetic predisposition, specifically the *HLA-B5801 allele, which is associated with an increased risk of SCARs in certain ethnic populations, including those of Han Chinese, Korean, and Thai descent. The drug is contraindicated** for initiation during an acute gout attack.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory information describes specific manifestations that may occur following an acute overdose of Prodec (Allopurinol), which involves ingesting an amount substantially higher than the prescribed dose. Documented signs include nausea, vomiting, diarrhea, dizziness, headache, and stomach pain. A key physiological concern noted in official labeling is the potential for massive absorption, resulting in considerable and sustained inhibition of xanthine oxidase activity.

Immediate actions are mandated by health authorities in all cases of suspected overdose. Individuals must seek immediate medical attention and contact emergency services or a Poison Control center right away. The management of overdose is defined by regulatory agencies as strictly symptomatic and supportive.

Treatment procedures documented in official prescribing information include ensuring the maintenance of adequate diuresis (hydration) and, for severe exposures, the potential necessity of haemodialysis for the rapid removal of Allopurinol and its active metabolite, oxipurinol. Furthermore, regulatory sources explicitly state that no specific antidote is known for Allopurinol overdose.

Population-specific warnings emphasize that patients with decreased renal function face an increased risk of drug and metabolite accumulation, which can heighten toxicity following an overdose.

Therapeutic Uses of Prodec

Prodec (Allopurinol) is commonly used to manage and prevent the health consequences associated with persistently high levels of uric acid (hyperuricemia) in the body. The medicine is relevant for managing symptoms related to systemic imbalance and supports long-term benefit.

The active ingredient, allopurinol, is used to treat gout and high levels of uric acid that build up in the blood during chemotherapy, as well as to treat recurrent kidney stones in patients with high levels of uric acid in their urine.


Primary Management of Chronic Gout and Crystal Deposits

This medication is applied in conditions characterized by periods of heightened symptoms stemming from crystal formation, namely chronic gout. It helps address symptom clusters that may become intense or disruptive, such as the severe joint pain, swelling, and inflammation during episodic gout attacks. Prodec provides support that helps ease the overall symptom burden by helping to manage the frequency of flares and may assist in the management of physical manifestations like tophi.


Preventing Uric Acid Kidney Stones and Renal Risk

Prodec is relevant in contexts marked by increased systemic burden where uric acid contributes to the formation of physical deposits. It is commonly used across conditions presenting with recurrent or episodic manifestations of painful uric acid kidney stones (nephrolithiasis). This use supports patients during difficult episodes by easing distress and supports renal health by contributing to the management of stone recurrence.


Prophylaxis for High-Risk Metabolic Crisis

The drug is commonly used when short-term symptomatic assistance is needed in clinical settings, such as for certain oncology patients (e.g., those with leukemia or lymphoma). The medication is applied when appropriate as a preventative measure before cytotoxic therapy to support the management of metabolic activity, and is relevant for supporting the management of acute hyperuricemia, a factor associated with Tumor Lysis Syndrome (TLS).


Core Therapeutic Indications and Patient Benefit

Prodec is commonly used for managing chronic gout, for supporting the management of uric acid kidney stones, and offering prophylactic support against acute hyperuricemia during cancer therapy. The medication is relevant for supporting the management of long-term metabolic stability, contributing to the management of the frequency of debilitating gout flares, easing distress associated with recurrent stone formation, and providing supportive relief during periods of heightened physiological stress.

“This medicine is relevant for managing symptoms that interfere with daily comfort, focusing on the systemic cause of recurrent, painful episodes.”

Quick Fact: Relief for Recurrent Joint Pain
Goal: To help manage uric acid levels over time, which assists in addressing the development of crystalline deposits and severe joint inflammation.

Regulatory References

  1. Allopurinol: MedlinePlus Drug Information

Eligibility and Restrictions for Use

Eligibility: Who Can and Cannot Use Prodec?

Prodec (Allopurinol) is intended for use in adult patients with signs of gout or recurrent uric acid kidney stones. It is also indicated for both adult and pediatric patients with hyperuricemia linked to cancer therapy (e.g., leukemia).

Contraindications (Must Not Use):

  • Patients with a known history of severe allergic reaction (hypersensitivity) to allopurinol.
  • Treatment must not be started during a current acute attack of gout.
  • Use is not recommended for patients with asymptomatic hyperuricemia.

Conditional and Restricted Use Populations:

Population Group Regulatory Status
Impaired Renal or Hepatic Function Use is conditional, requiring special caution due to the risk of drug accumulation and hypersensitivity.
*HLA-B58:01 Carriers** (Certain Asian groups) Not recommended unless benefits clearly outweigh risks, due to a high risk of severe skin reactions.
Pregnancy and Lactation Restricted use; should only be used if considered essential or absolutely required.
Pediatric Patients (General Use) Use is rarely indicated outside of malignancy-related hyperuricemia and specific congenital disorders.

Official documents define eligibility based on patient history, disease phase, organ function, and genetic risk factors, strictly defining the boundaries of safe use.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The interaction profile of Prodec (Allopurinol) is defined by its inhibitory effect on the enzyme Xanthine Oxidase (XO), which alters the metabolism and clearance of several co-administered medicines.

Formal Interaction Restrictions

Co-administration with Pegloticase is contraindicated and Prodec therapy must be discontinued during treatment with this agent. For Azathioprine and Mercaptopurine, co-administration requires a mandatory dose reduction of the thiopurine to approximately one-quarter of the usual dose. This restriction is essential because XO inhibition prevents the normal breakdown of these cytotoxic medicines, leading to potentially toxic systemic accumulation.

Pharmacokinetic and Pharmacodynamic Interactions

Interacting Agent Category Officially Documented Outcome
XO Substrates (e.g., Theophylline) Inhibition of metabolism, requiring drug level monitoring.
Coumarin Anticoagulants (e.g., Warfarin) Increased anticoagulant effect; necessitates coagulation status monitoring.
Chlorpropamide Increased risk of prolonged hypoglycaemia in patients with poor renal function due to renal clearance competition.
Aminopenicillins (e.g., Ampicillin) Associated with an increased frequency of skin rash.

Timing and Administration Constraints

Administration of Prodec must be separated by a three-hour gap from doses of Aluminum Hydroxide (Antacids) to prevent interference with Prodec's absorption. Additionally, concomitant use with Thiazide Diuretics in patients with renal impairment is associated with an increased risk of severe hypersensitivity reactions.

Mechanism of Action

How Prodec Works: Pharmacodynamic Mechanism

The mechanism of Prodec centers on the tight-binding inhibition of the enzyme Xanthine Oxidase (XO). The active molecule, a purine analogue, is converted by XO into its primary active metabolite, Oxipurinol. This metabolite then forms a stable, long-lasting complex with the XO enzyme, functionally locking it in an inactive state. This molecular action directly and fundamentally blocks the enzyme's capacity to catalyze the final steps of purine catabolism.

By halting XO activity, the drug modulates the pathway, resulting in the immediate accumulation of the intermediate substances, hypoxanthine and xanthine. This conversion cessation shifts the body’s metabolic balance, favoring the formation of these highly soluble precursors, which are readily cleared by the kidneys. This sustained enzymatic blockade is central to the resulting physiological consequence: a consistent reduction of serum urate concentration .

Dosage and Administration Information

Prodec is administered via two official methods: the oral tablet for chronic, long-term management and a specialized intravenous (IV) infusion used in acute, specialized settings, such as prophylaxis before certain cancer therapies. Oral therapy for chronic hyperuricemia begins with a starting dose of 100 mg once daily. This dose is then gradually increased, or titrated, in 100 mg increments at weekly intervals to achieve the desired metabolic control.


The typical maintenance dose ranges from 200 mg to 600 mg daily, but the total oral dose should not exceed 800 mg per day. For proper usage, oral tablets must be taken after meals to enhance gastrointestinal tolerance. While therapy is often once daily, any total daily oral dose exceeding 300 mg is designated for administration in divided doses. It is a key procedural condition that treatment must not be started during an acute gouty attack.


Specific adjustments are mandated for certain patient populations. Due to the way the body eliminates the drug, the dosage must be significantly reduced in the presence of renal impairment. For example, patients on dialysis may be given a dose of 300 mg to 400 mg immediately after each session. The IV formulation, which has a maximum dose of 600 mg per day, is typically initiated 24 to 48 hours before the start of chemotherapy, and adequate hydration is required during this period.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Prodec

This overview summarizes the official research describing Prodec (Allopurinol)'s clinical evaluation in authorized studies. The focus is on the types of evidence available, what outcomes were measured, and what remains uncertain.


Evidence for Management of Chronic Gout and Hyperuricemia

Research has focused extensively on the role of Prodec in conditions characterized by fluctuating or episodic manifestations of gout. Studies included long-term observational cohorts and shorter RCTs comparing Prodec against placebo or other treatments in adults.

Researchers primarily monitored changes in a key biomarker: the level of uric acid in the blood, known as serum urate (SU). Studies reported measurements of serum urate levels that were observed to be lower during the study period. Research also examined outcomes related to physical discomfort and tracked the frequency of acute gout flares and changes in the size and number of tophi (crystalline deposits) over time. Studies monitored these clinical patterns, and findings describe patterns observed in the studies where the tracking of acute gout attacks was monitored in the observed populations.

Research exploring the association with high-level outcomes, such as all-cause mortality or cardiovascular events, found mixed results across different trials and large observational studies. Additionally, some older studies used fixed doses which may have limited the insight into varying dose-response patterns. Long-term observational settings evaluating daily-life functioning described common patterns of non-persistence with the medication, which can be a research limitation in interpreting long-term outcomes.

Evidence for Preventing Acute Metabolic Crises (Tumor Lysis Syndrome)

This part will detail the short-term, acute-care research designed to evaluate Prodec's evaluation in research exploring prophylaxis in oncology patients at risk of rapid uric acid elevation, focusing on surrogate biomarkers and acute event tracking.

The main focus of these studies was to monitor the Plasma Uric Acid (PUA) concentration, a key biomarker used as a surrogate endpoint in this acute setting. Studies reported measurements where PUA levels were tracked and observed to be lower in certain study populations compared to control groups during the immediate high-risk period. While research examined the incidence of Laboratory Tumor Lysis Syndrome (TLS), data exploring high-level outcomes, such as the incidence of severe Clinical TLS (including acute kidney failure), remain more limited.


Gaps, Limitations, and Areas of Research Uncertainty

Despite the large volume of research, several research limitations and areas of uncertainty remain in the broader evidence landscape:

  • Impact on CKD Progression: Findings were mixed regarding the association with delaying the overall worsening of kidney function in patients with hyperuricemia and CKD, and certainty remains low in this area due to the heterogeneity of the studies.
  • Long-Term Cardiovascular Outcomes: While some observational studies was studied in association with cardiovascular outcomes, the results from randomized, controlled trials remain imprecise and ambiguous, suggesting that long-term effects are not fully established in this context.

Key Studies & References

  1. Allopurinol and renal impairment; a review on current findings (Focusing on CKD and Hyperuricemia)

Frequently Asked Questions (FAQ)

Common questions about Prodec (FAQ)

Q: Is Prodec the same type of medicine as [similar generic drug name]?

Prodec is the trade name for the active ingredient Allopurinol. According to official documents, this medicine is categorized as a Xanthine Oxidase Inhibitor (XOI). This is a specific pharmacological class of medicine whose primary purpose is to lower uric acid levels in the body.


Q: Are there any foods or drinks I should avoid while using Prodec?

Official guidance indicates there are no specific known food interactions; however, regulatory information suggests taking the tablets after meals to help reduce stomach upset. The effect of alcohol on the drug is not fully established, but official warnings state that alcohol consumption should be avoided.


Q: What is the main difference between Prodec and similar treatments?

Prodec (Allopurinol) works by tightly binding to and inhibiting the enzyme Xanthine Oxidase (XO), which is responsible for producing uric acid. Official information explains that this mechanism fundamentally blocks the final formation of uric acid. Other treatments for high uric acid may use a different approach, such as increasing the removal of uric acid by the kidneys.


Q: Are there different forms or strengths of Prodec available?

The active ingredient, Allopurinol, is available in multiple presentations. Official sources specify it comes in oral tablet forms, commonly in 100 mg, 200 mg, and 300 mg strengths. It is also supplied as a sterile powder used for intravenous injection in specialized acute care settings.


Q: Why is Prodec only used to treat specific conditions?

The medicine is indicated for specific conditions linked to high uric acid levels, known as hyperuricemia. This is due to its precise mechanism of action, which is limited to blocking the enzyme Xanthine Oxidase. Official documents explain that this selective action targets only the metabolic pathway related to uric acid production.


Q: Can Prodec be used if someone is allergic to other medicines?

The only official contraindication related to allergy is a known history of severe hypersensitivity (allergic reaction) to allopurinol itself. Official prescribing information stresses the necessity of informing a healthcare provider about all drug allergies, as part of the standard pre-treatment procedure.


Q: Does the time of day matter when taking Prodec?

Official administration instructions advise taking the tablets after a meal to help minimize potential stomach irritation. While the time of day can be flexible for a once-daily dose, taking it consistently at the same time each day may be suggested to help maintain stable drug levels.


Q: Can Prodec be used by individuals who are highly sensitive to medicines?

The drug is strictly contraindicated for individuals with a known hypersensitivity to allopurinol. Official documents also note that patients with impaired kidney function have an increased risk of severe allergic reactions. It is standard safety practice that patients inform their doctor of all past drug sensitivities.


Q: Has Prodec been studied in diverse patient populations?

Official labeling addresses use in specific populations, including those with impaired organ function and geriatric patients. Official warnings also note a *genetic risk factor (HLA-B58:01 allele)** associated with severe skin reactions in certain ethnic populations. This indicates a focus on specific population risks.


Q: Is there a generic version of Prodec available?

Yes, Prodec is a brand name. The active ingredient in Prodec is Allopurinol, which is widely available as an unbranded generic medicine.


Q: How quickly can I expect Prodec to start working?

The drug is rapidly converted into its primary active component, oxipurinol. Studies indicate that oxipurinol has a plasma half-life of approximately 15 hours. The full therapeutic effect of chronic treatment is achieved as the levels of oxipurinol stabilize in the blood.


Q: Do I need a prescription from a doctor to get Prodec?

According to regulatory classification, this medicine is available only with a doctor's prescription. It is not an over-the-counter medicine.


Q: Can Prodec make me feel tired or drowsy?

Official documents report that drowsiness and dizziness have occurred as side effects. Patients should be aware of these potential effects when starting the medicine.


Q: Does Prodec interact with common over-the-counter pain relievers?

The drug can typically be taken alongside common over-the-counter pain relievers such as acetaminophen (paracetamol) and non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen. However, Acetylsalicylic acid (aspirin) can decrease the efficacy of Allopurinol.


Q: Is Prodec safe for older adults to use?

Official guidance for older adults (geriatric patients) mandates that the lowest effective dosage be considered to achieve satisfactory uric acid reduction. This consideration is key because the drug’s elimination depends heavily on kidney function, which often changes with age.


Q: Will taking Prodec affect my ability to drive or operate machinery?

Official warnings caution that if drowsiness or dizziness occurs, tasks requiring mental alertness, like driving or operating machinery, should be avoided until the drug’s effects are known.


Q: How long does the effect of one dose of Prodec typically last?

The main active component, oxipurinol, has a plasma half-life of about 15 hours. This supports the drug’s ability to maintain effective inhibition of the target enzyme over a 24-hour period, which is why it is typically taken once daily.


Q: Can I take Prodec if I also have a chronic heart condition?

While having a chronic heart condition is not a strict contraindication, official documents specify that conditions like congestive heart failure must be reported to the healthcare provider prior to starting therapy. This information is used for comprehensive risk assessment.


Q: What if I'm taking herbal supplements—do they interact with Prodec?

Official drug labels often do not contain information about interactions with complementary or herbal remedies. This is because these products are generally not tested for drug-drug interactions in the same rigorous manner as prescription medicines.


Q: Is it safe to drink alcohol in moderation while using Prodec?

Official warnings state that alcohol consumption should be avoided. This is advised because alcohol may potentially worsen the underlying condition being treated, and combining it with the medicine can increase the risk of side effects such as dizziness.


Q: Are there any specific laboratory tests required before starting Prodec?

While there is no standard requirement for pre-treatment blood work for all patients, official documents note that the dosage may be adjusted based on specific laboratory results. This adjustment is based on measurements, such as 24-hour urinary urate determinations, to ensure therapeutic control.


Q: Can Prodec affect the results of any medical tests?

The drug is known to interact with certain medicines that require careful laboratory monitoring. For example, use with coumarin anticoagulants or theophylline necessitates the measurement of the patient's coagulation status or drug levels.

How should Prodec be stored and disposed of?

How to Store and Dispose of Prodec (Allopurinol)

Official regulatory guidelines require specific storage and disposal procedures for Prodec (Allopurinol) to maintain stability and ensure safety.

Storage Requirements

  • Temperature: The oral tablet form must be stored at Controlled Room Temperature, typically 20 C to 25 C (68 F to 77 F). The product must be kept away from excessive heat and must not be frozen.
  • Protection: The tablets must be protected from moisture and direct light and should remain in the tightly closed original container.
  • Intravenous (IV) Solution: The reconstituted IV solution must not be refrigerated and must be used within 10 hours of preparation.
  • Child Safety: All forms of the medicine must be stored out of the sight and reach of children.

Disposal Instructions

  • Preferred Method: Unused or expired medication should be disposed of via a drug take-back program or specialized mail-back envelope.
  • Alternative: If no take-back program is available, the drug may be mixed with an undesirable substance (e.g., dirt, used coffee grounds) and placed into a sealed container before disposal in household trash, complying with all local regulations.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Prodec found in:

A-Z Index: